vs

Side-by-side financial comparison of Red Cat Holdings, Inc. (RCAT) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.

Red Cat Holdings, Inc. is the larger business by last-quarter revenue ($9.6M vs $4.9M, roughly 2.0× Sensus Healthcare, Inc.). Sensus Healthcare, Inc. runs the higher net margin — -64.1% vs -166.0%, a 101.9% gap on every dollar of revenue. On growth, Red Cat Holdings, Inc. posted the faster year-over-year revenue change (988.2% vs -62.2%). Sensus Healthcare, Inc. produced more free cash flow last quarter ($-2.4M vs $-24.5M).

Mega Cat Studios is an American video game development and publishing company located in Pittsburgh, Pennsylvania. It was founded in 2015 by James Deighan, Nick Mann, and Zack Manko.

Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.

RCAT vs SRTS — Head-to-Head

Bigger by revenue
RCAT
RCAT
2.0× larger
RCAT
$9.6M
$4.9M
SRTS
Growing faster (revenue YoY)
RCAT
RCAT
+1050.4% gap
RCAT
988.2%
-62.2%
SRTS
Higher net margin
SRTS
SRTS
101.9% more per $
SRTS
-64.1%
-166.0%
RCAT
More free cash flow
SRTS
SRTS
$22.2M more FCF
SRTS
$-2.4M
$-24.5M
RCAT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
RCAT
RCAT
SRTS
SRTS
Revenue
$9.6M
$4.9M
Net Profit
$-16.0M
$-3.2M
Gross Margin
6.6%
38.4%
Operating Margin
-181.7%
-63.8%
Net Margin
-166.0%
-64.1%
Revenue YoY
988.2%
-62.2%
Net Profit YoY
-29.0%
-304.9%
EPS (diluted)
$-0.16
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCAT
RCAT
SRTS
SRTS
Q4 25
$4.9M
Q3 25
$9.6M
$6.9M
Q2 25
$7.3M
Q1 25
$1.6M
$8.3M
Q4 24
$0
$13.1M
Q3 24
$8.8M
Q2 24
$9.2M
Q1 24
$5.8M
$10.7M
Net Profit
RCAT
RCAT
SRTS
SRTS
Q4 25
$-3.2M
Q3 25
$-16.0M
$-943.0K
Q2 25
$-1.0M
Q1 25
$-23.1M
$-2.6M
Q4 24
$-13.3M
$1.5M
Q3 24
$1.2M
Q2 24
$1.6M
Q1 24
$-5.5M
$2.3M
Gross Margin
RCAT
RCAT
SRTS
SRTS
Q4 25
38.4%
Q3 25
6.6%
39.4%
Q2 25
39.7%
Q1 25
-52.2%
52.2%
Q4 24
54.4%
Q3 24
59.3%
Q2 24
58.7%
Q1 24
18.8%
62.5%
Operating Margin
RCAT
RCAT
SRTS
SRTS
Q4 25
-63.8%
Q3 25
-181.7%
-37.3%
Q2 25
-26.6%
Q1 25
-765.7%
-31.7%
Q4 24
13.2%
Q3 24
16.9%
Q2 24
21.5%
Q1 24
-76.0%
27.1%
Net Margin
RCAT
RCAT
SRTS
SRTS
Q4 25
-64.1%
Q3 25
-166.0%
-13.7%
Q2 25
-14.2%
Q1 25
-1418.9%
-30.8%
Q4 24
11.8%
Q3 24
13.7%
Q2 24
17.4%
Q1 24
-93.9%
21.3%
EPS (diluted)
RCAT
RCAT
SRTS
SRTS
Q4 25
$-0.19
Q3 25
$-0.16
$-0.06
Q2 25
$-0.06
Q1 25
$-0.27
$-0.16
Q4 24
$0.10
Q3 24
$0.07
Q2 24
$0.10
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCAT
RCAT
SRTS
SRTS
Cash + ST InvestmentsLiquidity on hand
$22.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$253.3M
$48.1M
Total Assets
$286.0M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCAT
RCAT
SRTS
SRTS
Q4 25
$22.1M
Q3 25
$24.5M
Q2 25
$22.2M
Q1 25
$19.1M
Q4 24
$22.1M
Q3 24
$22.6M
Q2 24
$19.0M
Q1 24
$14.7M
Stockholders' Equity
RCAT
RCAT
SRTS
SRTS
Q4 25
$48.1M
Q3 25
$253.3M
$51.2M
Q2 25
$52.1M
Q1 25
$28.9M
$53.0M
Q4 24
$27.0M
$55.8M
Q3 24
$54.1M
Q2 24
$52.9M
Q1 24
$49.6M
$51.2M
Total Assets
RCAT
RCAT
SRTS
SRTS
Q4 25
$53.0M
Q3 25
$286.0M
$58.3M
Q2 25
$58.9M
Q1 25
$59.7M
$60.2M
Q4 24
$51.1M
$62.2M
Q3 24
$59.9M
Q2 24
$58.2M
Q1 24
$55.3M
$57.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCAT
RCAT
SRTS
SRTS
Operating Cash FlowLast quarter
$-23.9M
$-2.2M
Free Cash FlowOCF − Capex
$-24.5M
$-2.4M
FCF MarginFCF / Revenue
-254.2%
-47.9%
Capex IntensityCapex / Revenue
6.9%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-55.0M
$332.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCAT
RCAT
SRTS
SRTS
Q4 25
$-2.2M
Q3 25
$-23.9M
$2.3M
Q2 25
$3.1M
Q1 25
$-15.9M
$-2.7M
Q4 24
$-10.1M
$-827.0K
Q3 24
$4.0M
Q2 24
$4.2M
Q1 24
$-4.1M
$-8.2M
Free Cash Flow
RCAT
RCAT
SRTS
SRTS
Q4 25
$-2.4M
Q3 25
$-24.5M
$2.3M
Q2 25
$3.1M
Q1 25
$-16.2M
$-2.7M
Q4 24
$-10.2M
$-1.1M
Q3 24
$3.6M
Q2 24
$4.2M
Q1 24
$-4.2M
$-8.4M
FCF Margin
RCAT
RCAT
SRTS
SRTS
Q4 25
-47.9%
Q3 25
-254.2%
33.3%
Q2 25
42.2%
Q1 25
-992.9%
-32.2%
Q4 24
-8.6%
Q3 24
40.9%
Q2 24
45.8%
Q1 24
-71.1%
-79.0%
Capex Intensity
RCAT
RCAT
SRTS
SRTS
Q4 25
3.2%
Q3 25
6.9%
0.1%
Q2 25
0.4%
Q1 25
16.8%
0.1%
Q4 24
2.3%
Q3 24
3.8%
Q2 24
0.0%
Q1 24
0.8%
2.2%
Cash Conversion
RCAT
RCAT
SRTS
SRTS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.53×
Q3 24
3.25×
Q2 24
2.62×
Q1 24
-3.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RCAT
RCAT

Products$8.5M88%
Services$1.2M12%

SRTS
SRTS

Products$2.8M57%
Other$2.1M43%

Related Comparisons